Merck Corporate Responsibility Report 2014 - Economics (optimized for printing)

Total revenues, sales, operating result (EBIT) and R&D costs, by division (€ million)

Merck Serono

Consumer Health

Performance Materials

Merck Millipore

Group*

*	As a non-operating segment, Corporate and Other is not shown here (see Annual Report 2014, Segment Reporting).
**	The previous year's figures have been adjusted (see Annual Report 2014, Notes on Segment Reporting).

2013**

Total revenues

6,060.4

745.0

1,644.4

2,645.3

11,095.1

Sales

5,688.4

742.1

1,642.1

2,627.5

10,700.1

Operating result (EBIT)

793.1

162.1

653.3

262.0

1,610.8

R&D costs

1,178.1

21.8

145.4

159.8

1,506.6

2014

Total revenues

5,975

768.8

2,060.5

2,696.5

11,500.8

Sales

5,783.3

766.1

2,059.6

2,682.5

11,291.5

Operating result (EBIT)

956.5

149.9

611.5

289.2

1,762.0

R&D costs

1,343.7

22.3

170.6

162.6

1,703.7

Indicators: Economics